{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:37:27Z","timestamp":1769549847827,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"am","delay-in-days":447,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.beem.2020.101427","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T12:23:23Z","timestamp":1589545403000},"page":"101427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Management of adrenal incidentalomas: Working through uncertainty"],"prefix":"10.1016","volume":"34","author":[{"given":"Sophie","family":"Cambos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2020.101427_bib1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib2","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management OF endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-1056","article-title":"Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population","volume":"178","author":"Marty","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/EJE-17-0372","article-title":"Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice","volume":"177","author":"Hong","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mayocpiqo.2017.11.002","article-title":"Clinical, biochemical, and radiological characteristics of a single-center retrospective cohort of 705 large adrenal tumors","volume":"2","author":"Iniguez-Ariza","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.beem.2020.101427_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/jc.2018-01532","article-title":"CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma","volume":"104","author":"Canu","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib7","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1210\/jc.2017-00254","article-title":"Performance of 18F-FDG PET\/CT in the characterization of adrenal masses in noncancer patients: a prospective study","volume":"102","author":"Guerin","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4158\/EP-2018-0616","article-title":"Large adrenal incidentalomas require a dedicated diagnostic procedure","volume":"25","author":"Amodru","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2020.101427_bib9","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-15-0175","article-title":"15 years OF paraganglioma: imaging and imaging-based treatment of pheochromocytoma and paraganglioma","volume":"22","author":"Castinetti","year":"2015","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.beem.2020.101427_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-18-0006","article-title":"Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study","volume":"178","author":"Buitenwerf","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib11","first-page":"3577","article-title":"Adrenal incidentaloma: machine learning-based quantitative texture analysis of unenhanced CT can effectively differentiate sPHEO from lipid-poor adrenal adenoma","volume":"9","author":"Yi","year":"2018","journal-title":"J\u00a0Canc"},{"key":"10.1016\/j.beem.2020.101427_bib12","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","article-title":"Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics","volume":"98","author":"Haissaguerre","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/jc.2018-01707","article-title":"Pheochromocytoma characteristics and behavior differ depending on method of discovery","volume":"104","author":"Gruber","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/jc.2014-2998","article-title":"Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas","volume":"100","author":"Lafont","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2265.2009.03551.x","article-title":"High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas","volume":"71","author":"Piaditis","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2020.101427_bib18","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1373\/clinchem.2016.255034","article-title":"Serum cortisol: an up-to-date assessment of routine assay performance","volume":"62","author":"Hawley","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2020.101427_bib19","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1176\/ajp.141.12.1550","article-title":"The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age","volume":"141","author":"Rosenbaum","year":"1984","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.beem.2020.101427_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrendo.2011.51","article-title":"Pros and cons of screening for occult Cushing syndrome","volume":"7","author":"Tabarin","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12020-017-1421-3","article-title":"Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma","volume":"59","author":"Ceccato","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2020.101427_bib22","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jc.2018-01029","article-title":"Suppressed ACTH is frequently unrelated to autonomous cortisol secretion in patients with adrenal incidentalomas","volume":"104","author":"Olsen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-10-0962","article-title":"Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of E. Assessment of ACTH assay variability: a multicenter study","volume":"164","author":"Pecori Giraldi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12020-017-1268-7","article-title":"Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism","volume":"56","author":"Yener","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2020.101427_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-09-0775","article-title":"Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?","volume":"162","author":"Eller-Vainicher","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib27","first-page":"786","article-title":"Low DHEAS: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas","volume":"102","author":"Dennedy","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib28","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2018-02349","article-title":"Plasma steroid profiles in subclinical compared with overt adrenal cushing syndrome","volume":"104","author":"Masjkur","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib29","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2020.101427_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2020.101427_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/EJE-17-0047","article-title":"Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks","volume":"177","author":"Morelli","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/EJE-17-0986","article-title":"Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas","volume":"178","author":"Sbardella","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib36","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","article-title":"Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion","volume":"99","author":"Androulakis","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\"Nonfunctional\" adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2020.101427_bib38","first-page":"105","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study","author":"Reimondo","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib39","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1210\/jc.2019-00365","article-title":"The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk","volume":"104","author":"Di Dalmazi","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cen.13145","article-title":"New diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the Co-work of Adrenal Research study","volume":"86","author":"Lee","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2020.101427_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cen.13512","article-title":"Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2020.101427_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12020-018-1598-0","article-title":"Alteration in skeletal muscle mass in women with subclinical hypercortisolism","volume":"61","author":"Kim","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2020.101427_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/EJE-17-0109","article-title":"Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome","volume":"177","author":"Di Dalmazi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib44","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1530\/EJE-16-0289","article-title":"Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review","volume":"175","author":"Chiodini","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib45","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1210\/jc.2016-1423","article-title":"Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas","volume":"101","author":"Morelli","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cen.13743","article-title":"Assessment of vertebral microarchitecture in overt and mild Cushing's syndrome using trabecular bone score","volume":"89","author":"Vinolas","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2020.101427_bib47","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00198-018-4608-4","article-title":"The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion","volume":"29","author":"Kim","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2020.101427_bib48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2020.101427_bib49","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy OF endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib50","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of cushing's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101427_bib51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4158\/EP-2019-0047","article-title":"Mifepristone treatment for mild autonomous cortisol secretion due to adrenal adenomas: a pilot study","volume":"25","author":"Belokovskaya","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2020.101427_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060984","article-title":"Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study","volume":"8","author":"Debono","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2020.101427_bib54","doi-asserted-by":"crossref","first-page":"K15","DOI":"10.1530\/EJE-17-0037","article-title":"From benign adrenal incidentaloma to adrenocortical carcinoma: an exceptional random event","volume":"176","author":"Belmihoub","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib55","doi-asserted-by":"crossref","first-page":"rjz200","DOI":"10.1093\/jscr\/rjz200","article-title":"Adrenocortical carcinoma arising from an adrenal adenoma in a young adult female","volume":"2019","author":"Rebielak","year":"2019","journal-title":"J\u00a0Surg Case Rep"},{"key":"10.1016\/j.beem.2020.101427_bib56","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12020-019-02066-w","article-title":"Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?","volume":"66","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2020.101427_bib57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imj.14332","article-title":"Three-year follow up of adrenal incidentalomas in a New Zealand centre","volume":"50","author":"Goh","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.beem.2020.101427_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/EJE-15-0199","article-title":"The clinical course of patients with adrenal incidentaloma: is it time to reconsider the current recommendations?","volume":"173","author":"Kastelan","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2020.101427_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/cen.13294","article-title":"Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up","volume":"86","author":"Papanastasiou","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2020.101427_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13048","article-title":"Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-up","volume":"49","author":"Ruiz","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.beem.2020.101427_bib61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-17-1071","article-title":"Significant prevalence of NR3C1 mutations in incidentally discovered bilateral adrenal hyperplasia: results of the French MUTA-GR Study","volume":"178","author":"Vitellius","year":"2018","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:04Z","timestamp":1761497824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X20300543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1521690X20300543"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2020.101427","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of adrenal incidentalomas: Working through uncertainty","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2020.101427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101427"}}